These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23174244)

  • 1. A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcome.
    Chung E; Garcia F; Young LD; Solomon M; Brock GB
    J Urol; 2013 Jan; 189(1):380-4. PubMed ID: 23174244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease.
    Trost LW; Ates E; Powers M; Sikka S; Hellstrom WJ
    J Urol; 2013 Dec; 190(6):2194-9. PubMed ID: 23688848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
    Moskovic DJ; Alex B; Choi JM; Nelson CJ; Mulhall JP
    BJU Int; 2011 Nov; 108(9):1485-9. PubMed ID: 21733073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response.
    Wolff B; Peyronnet B; Cattarino S; Mozer P; Renard-Penna R; Phé V; Bitker MO; Rouprêt M
    Urology; 2015 Jul; 86(1):57-61. PubMed ID: 26142583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
    Bivalacqua TJ; Diner EK; Novak TE; Vohra Y; Sikka SC; Champion HC; Kadowitz PJ; Hellstrom WJ
    J Urol; 2000 Jun; 163(6):1992-8. PubMed ID: 10799245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with intraplaque injection of verapamil for Peyronie's disease.
    Levine LA; Goldman KE; Greenfield JM
    J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
    Gallo L; Sarnacchiaro P
    Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
    Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
    J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peyronie disease in younger men: characteristics and treatment results.
    Levine LA; Estrada CR; Storm DW; Matkov TG
    J Androl; 2003; 24(1):27-32. PubMed ID: 12514077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
    Greenfield JM; Shah SJ; Levine LA
    J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
    Asali M; Asali M
    Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
    Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
    Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional verapamil injection for the treatment of Peyronie's disease.
    Levine LA; Merrick PF; Lee RC
    J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.